Magicbullet::reloaded - Collaborating on research into targeted cancer treatments
www.magicbullet-reloaded.eu
Surgery, radiation, and chemotherapy are the three main therapies used to treat cancerous tumors. The doctoral research network ‘Magicbullet::Reloaded’ is investigating another approach, with 15 doctoral researchers developing special molecules that stimulate the immune system to destroy tumor cells. In this video, network members explain how doctoral researchers gain valuable experience and research opportunities as part of the network.
Doctoral researchers from organic and medicinal chemistry, tumor biology, and pharmacology will be conducting research at the network through 2024. The collaborative training network consists of nine universities, two research institutions, and four pharmaceutical companies in Germany, Switzerland, the UK, Finland, Italy, and Hungary, and is also being supported by another four companies. Professor Dr. Norbert Sewald, a chemist at Bielefeld University, serves as network coordinator. The European Union is providing the network with approximately 4 million Euro in funding.
Since 2019, Magicbullet::Reloaded has been funded as a Marie Skłodowska-Curie Innovative Training Network with a total of approximately 4 million Euro as part of the European Union′s Horizon 2020 research and innovation programme (grant agreement No. 861316). The training network builds upon the research coordinated by Dr. Sewald from the ‘Magicbullet’ innovative training network that ran from 2015–2018.
